Sven Klijn | Senior Director, HEOR Evidence Acceleration & Innovation
Bristol Myers Squibb

Sven Klijn is Senior Director at Bristol Myers Squibb in the Global HEOR - Evidence Acceleration & Innovation (EAI) group, where he leads the innovative evidence and AI agenda in hematology and cell therapy. In addition, Sven has an active role in providing modeling and AI education at international congresses. He has widely published on innovative methods, especially in the fields of survival extrapolation and Generative AI. Sven has a training in public health and health economics and previously had various roles in CROs related to health-economic modeling.